A descriptive study of potential sight threatening event and severe visual loss following exposure to XALKORI (crizotinib)

ENCePP Code of conduct

No

Data sources

• Data sources (types):
  Other
• Data sources (types), other:
  Prospective patient-based data collection, Pfizer sponsored ongoing crizotinib clinical trials, Pfizer sponsored ongoing crizotinib NI Primary Data Collection studies, non Pfizer sponsored ongoing crizotinib clinical trials, and other solicited data sources.

Use of a Common Data Model (CDM)

• CDM mapping:
  No

Data quality specifications

• Check conformance:
  Unknown
• Check completeness:
  Unknown
• Check stability:
  Unknown
• Check logical consistency:
  Unknown

Data characterisation

• Data characterisation conducted:
  No